Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2023)
Verano Holdings (VRNO) posted quarterly Gains from Investment Securities of -$3.5 million for Q1 2023, up 27.18% year-over-year from -$2.7 million in Q1 2022, and down 365.86% quarter-over-quarter from -$744000.0 in Q4 2022.
Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2023) Analysis & Trends
Verano Holdings (VRNO) has reported Gains from Investment Securities for 3 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Gains from Investment Securities rose 27.18% year-over-year to -$3.5 million; the TTM figure through Dec 2023 stood at -$3.5 million (up 71.13% YoY), while the FY2023 annual figure was -$3.5 million, up 76.37% from the prior year.
- Gains from Investment Securities fell to -$3.5 million in Q1 2023 per VRNO's latest filing, from -$744000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.2 million in Q3 2021 and bottomed at -$6.0 million in Q2 2022.
- Historically, Gains from Investment Securities has averaged -$2.7 million across 3 years, with a median of -$3.5 million in 2023.
- On a YoY basis, Gains from Investment Securities climbed as much as 83.84% in 2022 and fell as far as 141.42% in 2022.
- Verano Holdings' Gains from Investment Securities stood at -$4.6 million in 2021, then surged by 83.84% to -$744000.0 in 2022, then slumped by 365.86% to -$3.5 million in 2023.
- Business Quant data shows VRNO's Gains from Investment Securities at -$3.5 million in Q1 2023, -$744000.0 in Q4 2022, and -$502000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -3.47 Mn |
| Mar 31, 2023 | -3.47 Mn |
| Dec 31, 2022 | -744,000.00 |
| Dec 31, 2022 | -744,000.00 |
| Sep 30, 2022 | -502,000.00 |
| Sep 30, 2022 | -502,000.00 |
| Jun 30, 2022 | -6.00 Mn |
| Jun 30, 2022 | -6.00 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | -4.60 Mn |
| Dec 31, 2021 | -4.60 Mn |
| Sep 30, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.21 Mn |